BUCCAL DRUG DELIVERY SYSTEM : HISTORY AND RECENT DEVELOPMENTS
DOI:
https://doi.org/10.22159/ajpcr.2016.v9i6.14041Abstract
Abstract
                  Of the various routes of drug delivery, the oral route is most ancient as well as preferred by the patient being convenient to take. However, peroral administration of drugs has short comings such as hepatic first-pass metabolism and enzymatic degradation within the GI-tract which comprehend a hindrance to the absorption of peptides and protein group of drug. The drug absorption takesplace faster as it is in contact with the absorption surface. The drug delivery system helps the drug to remain at the same place of application longer for once or twice daily dosing. For some drugs alternate way of administration results in novel methods of action as opposed to the above said procedure. The characteristics of the oral mucosa as well as physicochemical properties of the drug poses as a hindrance to the oral mucosal administration of some drugs. Commercial availability of drug is restricted, although most of the drugs are qualitatively assessed for oral transmucosal delivery. The clinical benefit produced by an oral transmucosal dosage form is good eventhough the production of this dosage form is expensive. Transmucosal products are the recent drug delivery strategies. Delivery through transmucosal benefits the absorption four times than that of skin. Considering the availability of products, only some drugs are used for oral transmucosal delivery. So new drugs have to be processed and developed inorder to meet the limited transmucosal drug delivery. Present paper intends to emphasis the importance of oral transmucosal drug delivery and also highlights on the latest advancement in the field.Â
Â
Downloads
References
Gandhi RB, Robinson JR. Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev 1994;13(1-2):43-74.
Semalty A, Semalty M, Singh R, Saraf SK, Saraf S. Properties and formulation of oral drug delivery systems of protein and peptides. Indian J Pharm Sci 2007;69(6):741-7.
Acharya RN, Baker JL. Us20016210699; 2001.
Harding SE, Davis SS, Deacon MP, Fiebrig I. Biopolymer mucoadhesives. Biotechnol Genet Eng Rev 1999;16:41-86.
Scrivener CA, Schantz CW. Penicillin: New methods for its use in dentistry. J Am Dent Assoc 1947;35:644-7.
Rothner JT, Cobe HM, Rosenthal SL, Bailin J. Adhesive penicillin ointment for topical application. J Dent Res 1949;28:544-8.
Keutscher AH, Zegarelli EV, Beube FE, Chiton NW. A new vehicle (orabase) for the application of drugs to the oral mucus membrane. Oral Pathol 1959;12:1080-9.
Chen JL, Cyr GN. Compositions producing adhesion through hydration. In: Manly RS, editor. Adhesion in Biological Systems. New York: Academic Press; 1970. p. 163-7.
Park JB. Acrylic bone cement: In vitro and in vivo property-structure relationship – A selective review. Ann Biomed Eng 1983;11(3-4):297-312.
Smart JD, Kellaway IW, Worthigton HE. An in vitro investigation of mucosa adhesive materials for use in controlled drug delivery. J Pharm Pharmacol 1984;36:295-9.
Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery – A promising option for orally less efficient drugs. J Control Release 2006;114:15-40.
Miyazaki S, Nakayama A, Oda M, Takada M, Attwood D. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biol Pharm Bull 1994;17(5):745-7.
Remunen-Lopez C, Portero A, Villa-Jato JL, Alonso MJ. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release 1998;55:143-52.
Taylan B, Capan Y, Guven O, Kes S, Hincal AA. Design and evaluation of sustained release and buccal adhesive propronolol hydrochloride tablets. J Control Release 1996;38(1):11-20.
Desai KG, Kumar TM. Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech 2004;5:1-9.
Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water - Soluble drugs. Drug Dev Ind Pharm 2004;30:995-1004.
Ahuja A, Khar RK, Ali J. Mucoadhesive drug delivery systems. Drug Dev Ind Pharm 1997;23(5):489-517.
Llabot JM, Manzo RH, Allemandi DA. Double-layered mucoadhesive tablets containing nystatin. AAPS PharmSciTech 2002;3:E22.
Bouckaert S, Schautteet H, Lefebvre RA, Remon JP, Clooster RV. Double - Layered mucoadhesive tablets containing nystatin. Eur J Clin Pharmacol 1992;43:137.
Gupta A, Garg S, Khar RK. Interpolymer complexation and its effect on bioadhesion strength and the solution characteristics of buccal drug delivery systems. Drug Dev Ind Pharm 1994;20:315-25.
Nagai T. Adhesive topical drug delivery systems. J Control Release 1985;2:121-34.
Nagai T, Konishi R. Buccal/gingival drug delivery systems. J Control Release 1987;6:353-60.
Nagai T, Machida Y. Buccal delivery systems using hydrogels. Adv Drug Del Rev 1993;11:179-91.
Ponchel G, Touchard F, Wouessidjewe D, Duchene D, Peppas NA. Bioadhesive analysis of controlled release system. III. Bioadhesive and release behavior of metronidazole containing poly hydroxypropyl methylcellulose systems. Int J Pharm 1987;38:65-70.
Bottenberg P, Cleymaet R, Mynck CD, Remenn JP, Coomans D, Michotte Y, et al. Comparison of salivary fluoride concentration after administration of a bioadhesive slow release tablet and a conventional fluoride tablet. J Pharm Pharmacol 1991;43:457.
Bouckaert S, Schautteet H, Lefebvre RA, Remon JP, Van Clooster R. Comparison of salivary miconazole concentrations after administrations of a bio adhesive slow - Release buccal tablet and an oral gel. Eur J Clin Pharmacol 1992;43:137-40.
Agarwal V, Mishra B. Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm 1999;25:701-9.
Alur HH, Pather SI, Mitra AK, Johnston TP. Transmucosal sustained - Delivery of chlorpheniramine maleate in rabbits using a novel natural mucoadhesive gum as an excipient in buccal tablets. Int J Pharm 1999;188:1-10.
Choi HG, Kim CK. Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J Control Release 2000;68(3):397-404.
Park CR, Munday DL. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharm 2002;237(1-2):215-26.
Rajesh K, Agarwal SP, Ahuja A. Buccoadhesive erodible carriers for local drug delivery: Design and standardization. Int J Pharm 1996;138:68-73.
Ikinci G, Senel S, Wilson CG, Sumnu M. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation. Int J Pharm 2004;277(1-2):173-8.
Mizrahi B, Golenser J, Wolnerman JS, Domb AJ. Adhesive tablet effective for treating canker sores in humans. J Pharm Sci 2004;93(12):2927-35.
Du Q, Ping QN, Liu GJ. Preparation of buspirone hydrochloride buccal adhesive tablet and study on its drug release mechanism. Yao Xue Xue Bao 2002;37(8):653-6.
Choi H, Jung J, Yong CS, Rhee C, Lee M, Han J, et al. Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J Control Release 2000;68(3):405-12.
Ceschel GC, Maffei P, Lombardi Borgia S, Ronchi C. Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv 2001;8(3):161-71.
Tsutsumi K, Obata Y, Nagai T, Loftsson T, Takayama K. Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs. Int J Pharm 2002;238(1-2):161-70.
Dinsheet SP, Ahuja AA. Preparation and evaluation of buccal adhesive tablets of Hydralazine hydrochloride. Indian J Pharm Sci 1997;59(3):135-41.
Rafiee-Tehrani M, Jazayeri G, Toliyat T, Bayati K, Khalkhali K, Shamimi K, et al. Development and in-vitro evaluation of novel buccoadhesive tablet formulation of prednisolone. Acta Pharm 2002;52:123-30.
Cassidy JP, Landzert NM, Quadros E. Controlled buccal delivery of buprenorphine. J Control Release 1993;25:21-9.
Anlar S, Capan Y, Güven O, Gögüs A, Dalkara T, Hincal AA. Formulation and in vitro-in vivo evaluation of buccoadhesive morphine sulfate tablets. Pharm Res 1994;11(2):231-6.
Goud HK, Kumar TM. Preparation and evaluation of a novel buccal adhesive systems. AAPS PharmSciTech 2004;5(3):35.
Bromberg LE, Buxton DK, Friden PM. Novel periodontal drug delivery system for treatment of periodontitis. J Control Release 2001;71(3):251-9.
Codd JE, Desay PB. Formulation, development and in vivo evaluation of a novel bioadhesive lozenge containing a synergistic combination of antifungal agents. Int J Pharm 1998;173:13-24.
He H, Cao X, Lee LJ. Design of a novel hydrogel-based intelligent system for controlled drug release. J Control Release 2004;95(3):391-402.
Cui Z, Mumper RJ. Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharm Res 2002;19(7):947-53.
Perugini P, Genta I, Conti B, Modena T, Pavanetto F. Periodontal delivery of ipriflavone: New chitosan/PLGA film delivery system for a lipophilic drug. Int J Pharm 2003;252(1-2):1-9.
Senel S, Ikinci G, Kas S, Yousefi-Rad A, Sargon MF, Hincal AA. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm 2000;193(2):197-203.
Tiwari D, Goldman D, Sause R, Madan PL. Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS Pharm Sci 1999;1:1-8.
Anders R, Merckle H. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int J Pharm 1989;49:231-40.
Anders R, Merkle HP, Schurr W, Ziegler R. Buccal absorption of protirelin: An effective way to stimulate thyrotropin and prolactin. J Pharm Sci 1983;72:1481-3.
Guo JH. Investigating the surface properties and bioadhesion of buccal patches. J Pharm Pharmacol 1994;46:647-50.
Danjo K, Kato H, Otsuka A, Ushimaru K. Fundamental study on the evaluation of strength of granular particles. Chem Pharm Bull 1994;42:2598-603.
Ishida M, Nambu N, Nagai T. Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and carbopol. Chem Pharm Bull (Tokyo) 1982;30(3):980-4.
Nafee NA, Ismail FA, Nabila A, Boraie LM. Mucoadhesive buccal patches of miconazole nitrate: In vitro/in vivo performance and effect of ageing. Int J Pharm 2003;264:1-14.
Save T, Shah MU, Ghamande AR, Venkitachalam P. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine. J Pharm Pharmacol 1994;46(3):192-5.
Shojaei AH, Li X. Mechanisms of buccal mucoadhesion of novel copolymers of acrylic acid and polyethylene glycol monomethylether monomethacrylate. J Control Release 1997;47:151-61.
Hoogstraate AJ, Verhoef JC, Pijpers A, Leengoed LA, Verheijden JH,
Junginger HE, et al. In vivo buccal delivery of the peptide drug buserilin with glycodeoxycholate as an absorption enhancer in pigs. Pharm Res 1996;13:1233-7.
Alur H, Beal JD, Pather SI, Mitra AK, Johnston JP. Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J Pharm Sci 1999;88(12):1313-9.
Yaziksiz-lscan Y, Capan Y, Senel S, Sahin MF, Kes S, Duchene D, et al. Formulation and in vitro/in vivo evaluation of buccal bioadhesive captopril tablets. S.T.P. Pharma. Pharm Sci 1998;8:357-63.
Ito Y, Hu Z, Yoshikawa M, Murakami M, Takada K. Proceedings International Symposium Control. Rel Bioact Mater 1999;26:6303-4.
McElnay JC, Al-Furaih TA, Hughes CM, Scott MG, Elborn JS, Nicholls DP. Buccal absorption of enalapril and lisinopril. Eur J Clin Pharmacol 1998;54(8):609-14.
Gutniak MK, Larsson H, Heiber SJ, Juneskans OT, Holst JJ, Ahrén B. Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet. Diabetes Care 1996;19(8):43-8.
Chien Y, Nakane S, Lee Y, Kukumoto M, Yukimatsu K. Proceeding Ist World Meeting APGI/APV. Budapest; 1995. p. 813-4.
Tovey MG, Maury C. Oromucosal interferon therapy: Marked antiviral and antitumor activity. J Interferon Cytokine Res 1999;19:145-55.
Zhang J, Nui S, Ebert C, Stanley TH. An in-vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers apparent evidence of effective enhancement without tissue damage. Int J Pharm 1994;101:15-22.
Nakane S, Kakumoto M, Yukimatsu K, Chien YW. Oramucosal delivery of LHRH: Pharmacokinetic studies of controlled and enhanced transmucosal permeation. Pharm Dev Technol 1996;1(3):251-9.
Merkle HP, Wolany GJ. Bioadhesion Method. J Control Release 1992;21:155-64.
Li C, Bhatt PP, Johnston TP. Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch. Pharm Dev Technol 1997;2(3):265-74.
Bayley D, Temple C, Clay V, Steward A, Lowther N. The transmucosal absorption of recombinant human interferon-alpha B/D hybrid in the rat and rabbit. J Pharm Pharmacol 1995;47:721-4.
Defelippis MR. Overcoming the challenges of noninvasive proteins and peptides delivery. Am Pharm Rev 2003;6:21-30.
Martin del valle EM, Galan MA, Carbonell RG. Drug delivery technologies: The way forward in the new decade. Ind Eng Chem Res 2009;48:2475-86.
Gotch F, Nadell J, Edelman IS. Gastrointestinal water and electrolytes. IV. The equilibration of Deuterium oxide in gastrointestinal contents and the proportion of total body water (T.B.W) in the gastrointestinal tract. J Clin Invest 1957;36:289-96.
Cummings JH, Banwell JG, Segal I, Coleman N, Englyst HN, Macfarlane GT. The amount and composition of large bowel contents in man. Gastroenterology 1990;98:A408.
Herrera JL, Lyons MF 2nd, Johnson LF. Saliva: Its role in health and disease. J Clin Gastroenterol 1988;10(5):569-78.
Slomiany BL, Murty VL, Piotrowski J, Slomiany A. Salivary mucins in oral mucosal defense. Gen Pharmacol 1996;27(5):761-71.
Li B, Robinson JR. Preclinical assessment of oral mucosal drug delivery systems. In: Ghosh TK, Pfister WR, editors. Drug Delivery to the Oral Cavity: Molecules to Market. Boca Raton, FL: CRC Press; 2005. p. 41-66.
Sohi H, Ahuja A, Ahmad FJ, Khar RK. Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm 2010;36:254-82.
Collins LM, Dawes C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res 1987;66:1300-2.
de Vries ME, Boddé HE, Verhoef JC, Junginger HE. Developments in buccal drug delivery. Crit Rev Ther Drug Carrier Syst 1991;8:271-303.
Squier CA, Nanny D. Measurement of blood flow in the oral mucosa and skin of the rhesus monkey using radiolabelled microspheres. Arch Oral Biol 1985;30:313-8.
Squier CA, Wertz PW. Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone MJ, editor. Oral Mucosal Drug Delivery. Vol. 74. New York: Marcel Dekker, Inc.; 1996. p. 1-26.
Diaz-Del Consuelo I, Jacques Y, Pizzolato GP, Guy RH, Falson F. Comparison of the lipid composition of porcine buccal and esophageal permeability barriers. Arch Oral Biol 2005;50:981-7.
Humphrey SP, Williamson RT. A review of saliva: Normal composition, flow, and function. J Prosthet Dent 2001;85:162-9.
Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992;81(1):1-10.
Galey WR, Lonsdale HK, Nacht S. The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water. J Invest Dermatol 1976;67(6):713-7.
Hayward AF. Membrane-coating granules. Int Rev Cytol 1979;59:97-127.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
